Rodney W. Lappe - Director at Design Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
DSGN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Rodney W. Lappe - trading volume in the past year for Design Therapeutics, Inc.

Holdings reported by Rodney W. Lappe for Design Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 133,024 $312 K $2.35 Sep 29, 2023 Direct
Stock Option (right to buy) 19,000 Jun 13, 2024 Direct Common Stock

Transactions reported by Rodney W. Lappe for Design Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership